Report Detail

Service & Software Covid-19 Impact on Global AI Drug Discovery Market Size, Status and Forecast 2020-2026

  • RnM3978141
  • |
  • 29 May, 2020
  • |
  • Global
  • |
  • 129 Pages
  • |
  • QYResearch
  • |
  • Service & Software

AI Drug Discovery market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global AI Drug Discovery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the AI Drug Discovery market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the AI Drug Discovery industry.

The key players covered in this study
Microsoft Corporation
NVIDIA Corporation
IBM Corporation
Google
Atomwise, Inc.
Deep Genomics
Cloud Pharmaceuticals, Inc.
Insilico Medicine
Benevolentai
Exscientia
Cyclica
Bioage
Numerate
Envisagenics
TwoXAR
Owkin, Inc.
Xtalpi, Inc.
Verge Genomics
Berg LLC

Market segment by Type, the product can be split into
Software
Services
Market segment by Application, split into
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Disease
Metabolic Diseases
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global AI Drug Discovery status, future forecast, growth opportunity, key market and key players.
To present the AI Drug Discovery development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of AI Drug Discovery are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by AI Drug Discovery Revenue
  • 1.4 Covid-19 Implications on Market by Type
    • 1.4.1 Global AI Drug Discovery Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Software
    • 1.4.3 Services
  • 1.5 Market by Application
    • 1.5.1 Global AI Drug Discovery Market Share by Application: 2020 VS 2026
    • 1.5.2 Immuno-Oncology
    • 1.5.3 Neurodegenerative Diseases
    • 1.5.4 Cardiovascular Disease
    • 1.5.5 Metabolic Diseases
    • 1.5.6 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): AI Drug Discovery Industry Impact
    • 1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.6.2 Covid-19 Impact: Commodity Prices Indices
    • 1.6.3 Covid-19 Impact: Global Major Government Policy
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends

  • 2.1 Covid-19 Implications on Global AI Drug Discovery Market Perspective (2015-2026)
  • 2.2 Covid-19 Implications on Global AI Drug Discovery Growth Trends by Regions
    • 2.2.1 AI Drug Discovery Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 AI Drug Discovery Historic Market Share by Regions (2015-2020)
    • 2.2.3 AI Drug Discovery Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 AI Drug Discovery Market Growth Strategy
    • 2.3.6 Primary Interviews with Key AI Drug Discovery Players (Opinion Leaders)

3 Covid-19 Implications on Competition Landscape by Key Players

  • 3.1 Global Top AI Drug Discovery Players by Market Size
    • 3.1.1 Global Top AI Drug Discovery Players by Revenue (2015-2020)
    • 3.1.2 Global AI Drug Discovery Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global AI Drug Discovery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global AI Drug Discovery Market Concentration Ratio
    • 3.2.1 Global AI Drug Discovery Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by AI Drug Discovery Revenue in 2019
  • 3.3 AI Drug Discovery Key Players Head office and Area Served
  • 3.4 Key Players AI Drug Discovery Product Solution and Service
  • 3.5 Date of Enter into AI Drug Discovery Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Covid-19 Implications on Market Size by Type (2015-2026)

  • 4.1 Global AI Drug Discovery Historic Market Size by Type (2015-2020)
  • 4.2 Global AI Drug Discovery Forecasted Market Size by Type (2021-2026)

5 Covid-19 Implications on Market Size by Application (2015-2026)

  • 5.1 Global AI Drug Discovery Market Size by Application (2015-2020)
  • 5.2 Global AI Drug Discovery Forecasted Market Size by Application (2021-2026)

6 North America Impact of COVID-19

  • 6.1 North America AI Drug Discovery Market Size (2015-2020)
  • 6.2 AI Drug Discovery Key Players in North America (2019-2020)
  • 6.3 North America AI Drug Discovery Market Size by Type (2015-2020)
  • 6.4 North America AI Drug Discovery Market Size by Application (2015-2020)

7 Europe Impact of COVID-19

  • 7.1 Europe AI Drug Discovery Market Size (2015-2020)
  • 7.2 AI Drug Discovery Key Players in Europe (2019-2020)
  • 7.3 Europe AI Drug Discovery Market Size by Type (2015-2020)
  • 7.4 Europe AI Drug Discovery Market Size by Application (2015-2020)

8 China Impact of COVID-19

  • 8.1 China AI Drug Discovery Market Size (2015-2020)
  • 8.2 AI Drug Discovery Key Players in China (2019-2020)
  • 8.3 China AI Drug Discovery Market Size by Type (2015-2020)
  • 8.4 China AI Drug Discovery Market Size by Application (2015-2020)

9 Japan Impact of COVID-19

  • 9.1 Japan AI Drug Discovery Market Size (2015-2020)
  • 9.2 AI Drug Discovery Key Players in Japan (2019-2020)
  • 9.3 Japan AI Drug Discovery Market Size by Type (2015-2020)
  • 9.4 Japan AI Drug Discovery Market Size by Application (2015-2020)

10 Southeast Asia Impact of COVID-19

  • 10.1 Southeast Asia AI Drug Discovery Market Size (2015-2020)
  • 10.2 AI Drug Discovery Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia AI Drug Discovery Market Size by Type (2015-2020)
  • 10.4 Southeast Asia AI Drug Discovery Market Size by Application (2015-2020)

11 India Impact of COVID-19

  • 11.1 India AI Drug Discovery Market Size (2015-2020)
  • 11.2 AI Drug Discovery Key Players in India (2019-2020)
  • 11.3 India AI Drug Discovery Market Size by Type (2015-2020)
  • 11.4 India AI Drug Discovery Market Size by Application (2015-2020)

12 Central & South America Impact of COVID-19

  • 12.1 Central & South America AI Drug Discovery Market Size (2015-2020)
  • 12.2 AI Drug Discovery Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America AI Drug Discovery Market Size by Type (2015-2020)
  • 12.4 Central & South America AI Drug Discovery Market Size by Application (2015-2020)

13Key Players Profiles

  • 13.1 Microsoft Corporation
    • 13.1.1 Microsoft Corporation Company Details
    • 13.1.2 Microsoft Corporation Business Overview and Its Total Revenue
    • 13.1.3 Microsoft Corporation AI Drug Discovery Introduction
    • 13.1.4 Microsoft Corporation Revenue in AI Drug Discovery Business (2015-2020))
    • 13.1.5 Microsoft Corporation Recent Development and Reaction to COVID-19
  • 13.2 NVIDIA Corporation
    • 13.2.1 NVIDIA Corporation Company Details
    • 13.2.2 NVIDIA Corporation Business Overview and Its Total Revenue
    • 13.2.3 NVIDIA Corporation AI Drug Discovery Introduction
    • 13.2.4 NVIDIA Corporation Revenue in AI Drug Discovery Business (2015-2020)
    • 13.2.5 NVIDIA Corporation Recent Development and Reaction to COVID-19
  • 13.3 IBM Corporation
    • 13.3.1 IBM Corporation Company Details
    • 13.3.2 IBM Corporation Business Overview and Its Total Revenue
    • 13.3.3 IBM Corporation AI Drug Discovery Introduction
    • 13.3.4 IBM Corporation Revenue in AI Drug Discovery Business (2015-2020)
    • 13.3.5 IBM Corporation Recent Development and Reaction to COVID-19
  • 13.4 Google
    • 13.4.1 Google Company Details
    • 13.4.2 Google Business Overview and Its Total Revenue
    • 13.4.3 Google AI Drug Discovery Introduction
    • 13.4.4 Google Revenue in AI Drug Discovery Business (2015-2020)
    • 13.4.5 Google Recent Development and Reaction to COVID-19
  • 13.5 Atomwise, Inc.
    • 13.5.1 Atomwise, Inc. Company Details
    • 13.5.2 Atomwise, Inc. Business Overview and Its Total Revenue
    • 13.5.3 Atomwise, Inc. AI Drug Discovery Introduction
    • 13.5.4 Atomwise, Inc. Revenue in AI Drug Discovery Business (2015-2020)
    • 13.5.5 Atomwise, Inc. Recent Development and Reaction to COVID-19
  • 13.6 Deep Genomics
    • 13.6.1 Deep Genomics Company Details
    • 13.6.2 Deep Genomics Business Overview and Its Total Revenue
    • 13.6.3 Deep Genomics AI Drug Discovery Introduction
    • 13.6.4 Deep Genomics Revenue in AI Drug Discovery Business (2015-2020)
    • 13.6.5 Deep Genomics Recent Development and Reaction to COVID-19
  • 13.7 Cloud Pharmaceuticals, Inc.
    • 13.7.1 Cloud Pharmaceuticals, Inc. Company Details
    • 13.7.2 Cloud Pharmaceuticals, Inc. Business Overview and Its Total Revenue
    • 13.7.3 Cloud Pharmaceuticals, Inc. AI Drug Discovery Introduction
    • 13.7.4 Cloud Pharmaceuticals, Inc. Revenue in AI Drug Discovery Business (2015-2020)
    • 13.7.5 Cloud Pharmaceuticals, Inc. Recent Development and Reaction to COVID-19
  • 13.8 Insilico Medicine
    • 13.8.1 Insilico Medicine Company Details
    • 13.8.2 Insilico Medicine Business Overview and Its Total Revenue
    • 13.8.3 Insilico Medicine AI Drug Discovery Introduction
    • 13.8.4 Insilico Medicine Revenue in AI Drug Discovery Business (2015-2020)
    • 13.8.5 Insilico Medicine Recent Development and Reaction to COVID-19
  • 13.9 Benevolentai
    • 13.9.1 Benevolentai Company Details
    • 13.9.2 Benevolentai Business Overview and Its Total Revenue
    • 13.9.3 Benevolentai AI Drug Discovery Introduction
    • 13.9.4 Benevolentai Revenue in AI Drug Discovery Business (2015-2020)
    • 13.9.5 Benevolentai Recent Development and Reaction to COVID-19
  • 13.10 Exscientia
    • 13.10.1 Exscientia Company Details
    • 13.10.2 Exscientia Business Overview and Its Total Revenue
    • 13.10.3 Exscientia AI Drug Discovery Introduction
    • 13.10.4 Exscientia Revenue in AI Drug Discovery Business (2015-2020)
    • 13.10.5 Exscientia Recent Development and Reaction to COVID-19
  • 13.11 Cyclica
    • 10.11.1 Cyclica Company Details
    • 10.11.2 Cyclica Business Overview and Its Total Revenue
    • 10.11.3 Cyclica AI Drug Discovery Introduction
    • 10.11.4 Cyclica Revenue in AI Drug Discovery Business (2015-2020)
    • 10.11.5 Cyclica Recent Development and Reaction to COVID-19
  • 13.12 Bioage
    • 10.12.1 Bioage Company Details
    • 10.12.2 Bioage Business Overview and Its Total Revenue
    • 10.12.3 Bioage AI Drug Discovery Introduction
    • 10.12.4 Bioage Revenue in AI Drug Discovery Business (2015-2020)
    • 10.12.5 Bioage Recent Development and Reaction to COVID-19
  • 13.13 Numerate
    • 10.13.1 Numerate Company Details
    • 10.13.2 Numerate Business Overview and Its Total Revenue
    • 10.13.3 Numerate AI Drug Discovery Introduction
    • 10.13.4 Numerate Revenue in AI Drug Discovery Business (2015-2020)
    • 10.13.5 Numerate Recent Development and Reaction to COVID-19
  • 13.14 Envisagenics
    • 10.14.1 Envisagenics Company Details
    • 10.14.2 Envisagenics Business Overview and Its Total Revenue
    • 10.14.3 Envisagenics AI Drug Discovery Introduction
    • 10.14.4 Envisagenics Revenue in AI Drug Discovery Business (2015-2020)
    • 10.14.5 Envisagenics Recent Development and Reaction to COVID-19
  • 13.15 TwoXAR
    • 10.15.1 TwoXAR Company Details
    • 10.15.2 TwoXAR Business Overview and Its Total Revenue
    • 10.15.3 TwoXAR AI Drug Discovery Introduction
    • 10.15.4 TwoXAR Revenue in AI Drug Discovery Business (2015-2020)
    • 10.15.5 TwoXAR Recent Development and Reaction to COVID-19
  • 13.16 Owkin, Inc.
    • 10.16.1 Owkin, Inc. Company Details
    • 10.16.2 Owkin, Inc. Business Overview and Its Total Revenue
    • 10.16.3 Owkin, Inc. AI Drug Discovery Introduction
    • 10.16.4 Owkin, Inc. Revenue in AI Drug Discovery Business (2015-2020)
    • 10.16.5 Owkin, Inc. Recent Development and Reaction to COVID-19
  • 13.17 Xtalpi, Inc.
    • 10.17.1 Xtalpi, Inc. Company Details
    • 10.17.2 Xtalpi, Inc. Business Overview and Its Total Revenue
    • 10.17.3 Xtalpi, Inc. AI Drug Discovery Introduction
    • 10.17.4 Xtalpi, Inc. Revenue in AI Drug Discovery Business (2015-2020)
    • 10.17.5 Xtalpi, Inc. Recent Development and Reaction to COVID-19
  • 13.18 Verge Genomics
    • 10.18.1 Verge Genomics Company Details
    • 10.18.2 Verge Genomics Business Overview and Its Total Revenue
    • 10.18.3 Verge Genomics AI Drug Discovery Introduction
    • 10.18.4 Verge Genomics Revenue in AI Drug Discovery Business (2015-2020)
    • 10.18.5 Verge Genomics Recent Development and Reaction to COVID-19
  • 13.19 Berg LLC
    • 10.19.1 Berg LLC Company Details
    • 10.19.2 Berg LLC Business Overview and Its Total Revenue
    • 10.19.3 Berg LLC AI Drug Discovery Introduction
    • 10.19.4 Berg LLC Revenue in AI Drug Discovery Business (2015-2020)
    • 10.19.5 Berg LLC Recent Development and Reaction to COVID-19

14Analyst's Viewpoints/Conclusions

    15Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Summary:
    Get latest Market Research Reports on AI Drug Discovery. Industry analysis & Market Report on AI Drug Discovery is a syndicated market report, published as Covid-19 Impact on Global AI Drug Discovery Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of AI Drug Discovery market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,116.10
    4,674.15
    6,232.20
    3,638.70
    5,458.05
    7,277.40
    606,645.00
    909,967.50
    1,213,290.00
    324,987.00
    487,480.50
    649,974.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report